候选的SARS-CoV-2mRNA疫苗候选人编码RBD奇梅拉Delta和Omicron变种:免疫性潜力和验证
Shahla Shahsavandi1, Sina Soleimani1, Majid Tebyanian1
1Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization, Karaj, Iran.
Iranian journal of microbiology
|November 14, 2025
概括
使者RNA (mRNA) 疫苗在对抗SARS-CoV-2变种方面表现有前途. 这项研究表明,mRNA脂质纳米粒子疫苗有效诱导小鼠的强效抗体和T细胞反应,没有观察到毒性.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 病毒学 病毒学
背景情况:
- 新出现的SARS-CoV-2变种对全球健康构成挑战,原因是频繁发生的突变减少了疫苗的有效性.
- 使者RNA (mRNA) 疫苗为强大的T细胞免疫反应提供了一个有希望的平台.
- 对抗不断演变的病毒株的有效疫苗的开发至关重要.
研究的目的:
- 评估用脂质纳米颗粒 (LNP) 配制的mRNA疫苗候选人的细胞吸收和免疫反应诱导.
- 评估mRNA-LNP候选疫苗的安全性.
- 确定mRNA疫苗对新出现的SARS-CoV-2变种的潜力.
主要方法:
- 通过eGFP表达评估了mRNA-LNP通过树突细胞的吸收.
- 评估了小鼠的免疫反应诱导 (抗体和T细胞) 使用主要增强策略.
- 进行了安全评估,包括燃烧性,毒性和组织病理学检查.
主要成果:
- mRNA-LNP被免疫细胞有效地吸收并迁移到淋巴结.
- 肌肉内注射诱导了强大的S蛋白特异抗体和Th1偏差细胞介导免疫与增强的IFN-γ表达.
- 候选疫苗表现出良好的安全性,没有明显的炎症或局部反应.
结论:
- 这种mRNA-LNP候选疫苗有效地引起强烈的幽默和细胞免疫力.
- 它向免疫细胞的能力表明,它有可能改善对当前和未来的SARS-CoV-2变种的反应.
- 候选疫苗表现出良好的安全性,支持其进一步发展.
更多相关视频
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
3.0K
06:08Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
1.7K
相关概念视频
00:36Viral Mutations
33.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
33.0K
02:28Leaky Scanning
4.5K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
4.5K
01:05Single Nucleotide Polymorphisms-SNPs
14.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.6K
01:29Viruses with RNA Genomes
1.5K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.5K